Company news
Olema Pharmaceuticals, Inc. news in 2022
Olema Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.
Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation Study
December 6, 2022
Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS)
November 20, 2022
Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 7, 2022
Olema Oncology to Present at Upcoming Investor Conferences in November
October 31, 2022
Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical Trial
October 25, 2022
Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 11, 2022
Olema Oncology to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 5, 2022
Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 8, 2022
Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer
August 8, 2022
Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference
August 3, 2022
Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast Cancer
July 20, 2022
Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development Program
June 8, 2022
Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies
June 8, 2022
Olema Oncology to Present at Jefferies Healthcare Conference
May 23, 2022
Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 8, 2022
Olema Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 17, 2022
Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 3, 2022
Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022
March 7, 2022
Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
February 27, 2022
Olema Oncology to Present at Cowen 42nd Annual Health Care Conference
February 21, 2022
Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer
January 30, 2022
Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference
January 3, 2022
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 36 slides · November 2022